Rhythm Pharmaceuticals, Inc. RYTM

Updated: 9 Sep 2026

NASDAQ | Biotech | Biopharmaceuticals / Rare Diseases

No signal published yet

We already track Rhythm Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Rhythm Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals / Rare Diseases
We're already tracking Rhythm Pharmaceuticals, Inc. — here are the latest events we've registered

Recent News

  • On August 24, 2026, Rhythm Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare granted marketing authorization for IMCIVREE (setmelanotide) to treat acquired hypothalamic obesity. This represents the first regulatory approval for this condition in Japan and is backed by data from the Phase 3 TRANSCEND trial. Earlier in the month, on August 4, 2026, the company reported second-quarter net product revenue of $71.3 million.

What Firelda Watch includes for Rhythm Pharmaceuticals, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Rhythm Pharmaceuticals, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Vicore Pharma Holding AB (publ)
VICO
HOLD
Cereno Scientific B
CRNO B
NEUTRAL
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL

Biotech

More companies in this sector

Want to follow Rhythm Pharmaceuticals, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Rhythm Pharmaceuticals free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Rhythm Pharmaceuticals, Inc. RYTM
Rhythm Pharmaceuticals — follow and we'll monitor it
Follow Rhythm Pharmaceuticals free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.